Skip to main content
Erschienen in: Clinical Pharmacokinetics 9/2005

01.09.2005 | Review Article

Microdialysis

Current Applications in Clinical Pharmacokinetic Studies and its Potential Role in the Future

verfasst von: Dr Christian Joukhadar, Markus Müller

Erschienen in: Clinical Pharmacokinetics | Ausgabe 9/2005

Einloggen, um Zugang zu erhalten

Abstract

Microdialysis is a probe-based sampling method, which, if linked to analytical devices, allows for the measurement of drug concentration profiles in selected tissues. During the last two decades, microdialysis has become increasingly popular for preclinical and clinical pharmacokinetic studies. The advantage of in vivo microdialysis over traditional methods relates to its ability to continuously sample the unbound drug fraction in the interstitial space fluid (ISF). This is of particular importance because the ISF may be regarded as the actual target compartment for many drugs, e.g. antimicrobial agents or other drugs mediating their action through surface receptors. In contrast, plasma concentrations are increasingly recognised as inadequately predicting tissue drug concentrations and therapeutic success in many patient populations. Thus, the minimally invasive microdialysis technique has evolved into an important tool for the direct assessment of drug concentrations at the site of drug delivery in virtually all tissues. In particular, concentrations of transdermally applied drugs, neurotransmitters, antibacterials, cytotoxic agents, hormones, large molecules such as cytokines and proteins, and many other compounds were described by means of microdialysis.
The combined use of microdialysis with non-invasive imaging methods such as positron emission tomography and single photon emission tomography opened the window to exactly explore and describe the fate and pharmacokinetics of a drug in the body. Linking pharmacokinetic data from the ISF to pharmacodynamic information appears to be a straightforward approach to predicting drug action and therapeutic success, and may be used for decision making for adequate drug administration and dosing regimens. Hence, microdialysis is nowadays used in clinical studies to test new drug candidates that are in the pharmaceutical industry drug development pipeline.
Literatur
1.
Zurück zum Zitat Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for failure in patients with septic shock. Crit Care Med 2001; 29: 385–91PubMedCrossRef Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for failure in patients with septic shock. Crit Care Med 2001; 29: 385–91PubMedCrossRef
2.
Zurück zum Zitat Tegeder I, Schmidtko A, Brautigam L, et al. Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther 2002; 71: 325–33PubMedCrossRef Tegeder I, Schmidtko A, Brautigam L, et al. Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther 2002; 71: 325–33PubMedCrossRef
3.
Zurück zum Zitat Brunner M, Pernerstorfer T, Mayer BX, et al. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 2000; 28: 1754–9PubMedCrossRef Brunner M, Pernerstorfer T, Mayer BX, et al. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 2000; 28: 1754–9PubMedCrossRef
4.
Zurück zum Zitat Namour F, Sultan E, Pascual MH, et al. Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration. J Antimicrob Chemother 2002; 49: 1035–8PubMedCrossRef Namour F, Sultan E, Pascual MH, et al. Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration. J Antimicrob Chemother 2002; 49: 1035–8PubMedCrossRef
5.
Zurück zum Zitat Walstad RA, Helium KB, Thurmann-Nielsen E, et al. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid. J Antimicrob Chemother 1986; 17 Suppl. C: 71–80PubMedCrossRef Walstad RA, Helium KB, Thurmann-Nielsen E, et al. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid. J Antimicrob Chemother 1986; 17 Suppl. C: 71–80PubMedCrossRef
6.
Zurück zum Zitat Mazzei T, Novelli A, Esposito S, et al. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients. J Chemother 2000; 12: 306–13PubMed Mazzei T, Novelli A, Esposito S, et al. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients. J Chemother 2000; 12: 306–13PubMed
7.
Zurück zum Zitat Richer M, Allard S, Manseau L, et al. Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses. Antimicrob Agents Chemother 1995; 39: 1082–6PubMedCrossRef Richer M, Allard S, Manseau L, et al. Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses. Antimicrob Agents Chemother 1995; 39: 1082–6PubMedCrossRef
8.
Zurück zum Zitat Borg N, Gotharson E, Benfeldt E, et al. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm Venereol 1999; 79: 274–7PubMedCrossRef Borg N, Gotharson E, Benfeldt E, et al. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm Venereol 1999; 79: 274–7PubMedCrossRef
9.
Zurück zum Zitat Holm SE. Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl 1978; 13: 47–51PubMed Holm SE. Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl 1978; 13: 47–51PubMed
10.
Zurück zum Zitat Varela JE, Cohn SM, Brown M, et al. Pharmacokinetics and burn eschar penetration of intravenous Ciprofloxacin in patients with major thermal injuries. J Antimicrob Chemother 2000; 45: 337–42PubMedCrossRef Varela JE, Cohn SM, Brown M, et al. Pharmacokinetics and burn eschar penetration of intravenous Ciprofloxacin in patients with major thermal injuries. J Antimicrob Chemother 2000; 45: 337–42PubMedCrossRef
11.
Zurück zum Zitat Licitra CM, Brooks RG, Sieger BE. Clinical efficacy and levels of Ciprofloxacin in tissue in patients with soft tissue infection. Antimicrob Agents Chemother 1987; 31: 805–7PubMedCrossRef Licitra CM, Brooks RG, Sieger BE. Clinical efficacy and levels of Ciprofloxacin in tissue in patients with soft tissue infection. Antimicrob Agents Chemother 1987; 31: 805–7PubMedCrossRef
12.
Zurück zum Zitat Birmingham MC, Guarino R, Heller A, et al. Ciprofloxacin concentrations in lung tissue following a single 400mg intravenous dose. J Antimicrob Chemother 1999; 43 Suppl. A: 43–8PubMedCrossRef Birmingham MC, Guarino R, Heller A, et al. Ciprofloxacin concentrations in lung tissue following a single 400mg intravenous dose. J Antimicrob Chemother 1999; 43 Suppl. A: 43–8PubMedCrossRef
13.
Zurück zum Zitat Daschner F. Tobramycin serum levels and tissue content in children. Chemotherapy 1977; 23: 293–8PubMedCrossRef Daschner F. Tobramycin serum levels and tissue content in children. Chemotherapy 1977; 23: 293–8PubMedCrossRef
14.
Zurück zum Zitat Bergeron MG. The pharmacokinetics and tissue penetration of the fluoroquinolones. Clin Invest Med 1989; 12: 20–7PubMed Bergeron MG. The pharmacokinetics and tissue penetration of the fluoroquinolones. Clin Invest Med 1989; 12: 20–7PubMed
15.
Zurück zum Zitat Sidhu P, Shojaee Aliabadi F, Andrews M, et al. Tissue chamber model of acute inflammation in farm animal species. Res Vet Sci 2003; 74: 67–77PubMedCrossRef Sidhu P, Shojaee Aliabadi F, Andrews M, et al. Tissue chamber model of acute inflammation in farm animal species. Res Vet Sci 2003; 74: 67–77PubMedCrossRef
16.
Zurück zum Zitat Cheng Z, Nolan AM, McKellar QA. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep. Inflammation 1998; 22: 353–66PubMedCrossRef Cheng Z, Nolan AM, McKellar QA. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep. Inflammation 1998; 22: 353–66PubMedCrossRef
17.
Zurück zum Zitat Bergan T. Kinetics of tissue penetration: are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy? Scand J Infect Dis Suppl 1978; 14: 36–46PubMed Bergan T. Kinetics of tissue penetration: are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy? Scand J Infect Dis Suppl 1978; 14: 36–46PubMed
18.
Zurück zum Zitat Rylander M, Holm SE, Norrby R, et al. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages. Scand J Infect Dis Suppl 1978; 13: 52–7PubMed Rylander M, Holm SE, Norrby R, et al. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages. Scand J Infect Dis Suppl 1978; 13: 52–7PubMed
19.
Zurück zum Zitat Petrakis I, Vrachassotakis N, Tsatsakis A, et al. Prospective study of preincisional single-dose ceftriaxone in reducing postoperative wound infection in high risk of infection patients. Eur Rev Med Pharmacol Sci 1998; 2: 141–5PubMed Petrakis I, Vrachassotakis N, Tsatsakis A, et al. Prospective study of preincisional single-dose ceftriaxone in reducing postoperative wound infection in high risk of infection patients. Eur Rev Med Pharmacol Sci 1998; 2: 141–5PubMed
20.
Zurück zum Zitat Blaser J, Rieder HL, Luthy R. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother 1991; 35: 837–9PubMedCrossRef Blaser J, Rieder HL, Luthy R. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother 1991; 35: 837–9PubMedCrossRef
21.
Zurück zum Zitat Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11: 470–82PubMedCrossRef Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11: 470–82PubMedCrossRef
22.
Zurück zum Zitat Barza M, Cuchural G. General principles of antibiotic tissue penetration. J Antimicrob Chemother 1985; 15 Suppl. A: 59–75PubMedCrossRef Barza M, Cuchural G. General principles of antibiotic tissue penetration. J Antimicrob Chemother 1985; 15 Suppl. A: 59–75PubMedCrossRef
23.
Zurück zum Zitat de Lange EC, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 2002; 41: 691–703PubMedCrossRef de Lange EC, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 2002; 41: 691–703PubMedCrossRef
24.
Zurück zum Zitat Curry FE. Determinants of capillary permeability: a review of mechanisms based on single capillary studies in the frog. Circ Res 1986; 59: 367–80PubMedCrossRef Curry FE. Determinants of capillary permeability: a review of mechanisms based on single capillary studies in the frog. Circ Res 1986; 59: 367–80PubMedCrossRef
25.
26.
Zurück zum Zitat Michel CC. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol 1980; 309: 341–55PubMed Michel CC. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol 1980; 309: 341–55PubMed
27.
Zurück zum Zitat Joukhadar C, Klein N, Frossard M, et al. Angioplasty increases target site concentrations of Ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther 2001; 70: 532–9PubMedCrossRef Joukhadar C, Klein N, Frossard M, et al. Angioplasty increases target site concentrations of Ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther 2001; 70: 532–9PubMedCrossRef
28.
Zurück zum Zitat Clough GF, Boutsiouki P, Church MK, et al. Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002; 302: 681–6PubMedCrossRef Clough GF, Boutsiouki P, Church MK, et al. Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002; 302: 681–6PubMedCrossRef
29.
Zurück zum Zitat Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148: 434–43PubMedCrossRef Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148: 434–43PubMedCrossRef
30.
Zurück zum Zitat Stahle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis: III. Extracellular concentration of caffeine in adipose tissue in man. Life Sci 1991; 49: 1853–8PubMedCrossRef Stahle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis: III. Extracellular concentration of caffeine in adipose tissue in man. Life Sci 1991; 49: 1853–8PubMedCrossRef
31.
Zurück zum Zitat Lonnroth P. Microdialysis: a new and promising method in clinical medicine. J Intern Med 1991; 230: 363–4PubMedCrossRef Lonnroth P. Microdialysis: a new and promising method in clinical medicine. J Intern Med 1991; 230: 363–4PubMedCrossRef
32.
Zurück zum Zitat Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993; 31 Suppl. D: 1–16PubMedCrossRef Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993; 31 Suppl. D: 1–16PubMedCrossRef
33.
Zurück zum Zitat Brunner M, Stabeta H, Moller JG, et al. Target site concentrations of Ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 2002; 46: 3724–30PubMedCrossRef Brunner M, Stabeta H, Moller JG, et al. Target site concentrations of Ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 2002; 46: 3724–30PubMedCrossRef
34.
Zurück zum Zitat Frossard M, Joukhadar C, Steffen G, et al. Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptorinhibition on transcapillary glucose transport in humans. Life Sci 2000; 66: PL147–54PubMedCrossRef Frossard M, Joukhadar C, Steffen G, et al. Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptorinhibition on transcapillary glucose transport in humans. Life Sci 2000; 66: PL147–54PubMedCrossRef
35.
Zurück zum Zitat Langberg H, Olesen JL, Gemmer C, et al. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 2002; 542: 985–90PubMedCrossRef Langberg H, Olesen JL, Gemmer C, et al. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 2002; 542: 985–90PubMedCrossRef
36.
Zurück zum Zitat Langberg H, Olesen JL, Bulow J, et al. Intra- and peri-tendinous microdialysis determination of glucose and lactate in pigs. Acta Physiol Scand 2002; 174: 377–80PubMedCrossRef Langberg H, Olesen JL, Bulow J, et al. Intra- and peri-tendinous microdialysis determination of glucose and lactate in pigs. Acta Physiol Scand 2002; 174: 377–80PubMedCrossRef
37.
Zurück zum Zitat Kennergren C, Mantovani V, Strindberg L, et al. Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest. Am J Physiol Endocrinol Metab 2003; 284: E788–94PubMed Kennergren C, Mantovani V, Strindberg L, et al. Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest. Am J Physiol Endocrinol Metab 2003; 284: E788–94PubMed
38.
Zurück zum Zitat Kennergren C, Mantovani V, Lonnroth P, et al. Extracellular amino acids as markers of myocardial ischemia during cardioplegic heart arrest. Cardiology 1999; 91: 31–40PubMedCrossRef Kennergren C, Mantovani V, Lonnroth P, et al. Extracellular amino acids as markers of myocardial ischemia during cardioplegic heart arrest. Cardiology 1999; 91: 31–40PubMedCrossRef
39.
Zurück zum Zitat Mindermann T, Zimmerli W, Gratzl O. Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother 1998; 42: 2626–9PubMed Mindermann T, Zimmerli W, Gratzl O. Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother 1998; 42: 2626–9PubMed
40.
Zurück zum Zitat Thorsen K, Kristoffersson AO, Lerner UH, et al. In situ microdialysis in bone tissue: stimulation of Prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest 1996; 98: 2446–9PubMedCrossRef Thorsen K, Kristoffersson AO, Lerner UH, et al. In situ microdialysis in bone tissue: stimulation of Prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest 1996; 98: 2446–9PubMedCrossRef
41.
Zurück zum Zitat Herkner H, Muller MR, Kreischitz N, et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med 2002; 165: 273–6PubMed Herkner H, Muller MR, Kreischitz N, et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med 2002; 165: 273–6PubMed
42.
Zurück zum Zitat Blochl-Daum B, Muller M, Meisinger V, et al. Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis. Br J Cancer 1996; 73: 920–4PubMedCrossRef Blochl-Daum B, Muller M, Meisinger V, et al. Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis. Br J Cancer 1996; 73: 920–4PubMedCrossRef
43.
Zurück zum Zitat Mader RM, Schrolnberger C, Rizovski B, et al. Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer. Br J Cancer 2003; 88: 782–7PubMedCrossRef Mader RM, Schrolnberger C, Rizovski B, et al. Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer. Br J Cancer 2003; 88: 782–7PubMedCrossRef
44.
Zurück zum Zitat Müller M, Mader RM, Steiner B, et al. 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res 1997; 57: 2598–601PubMed Müller M, Mader RM, Steiner B, et al. 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res 1997; 57: 2598–601PubMed
45.
Zurück zum Zitat Muller M, Brunner M, Schmid R, et al. Interstitial methotrexate kinetics in primary breast cancer lesions. Cancer Res 1998; 58: 2982–5PubMed Muller M, Brunner M, Schmid R, et al. Interstitial methotrexate kinetics in primary breast cancer lesions. Cancer Res 1998; 58: 2982–5PubMed
46.
Zurück zum Zitat Joukhadar C, Klein N, Mader RM, et al. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Cancer 2001; 92: 2190–6PubMedCrossRef Joukhadar C, Klein N, Mader RM, et al. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Cancer 2001; 92: 2190–6PubMedCrossRef
47.
Zurück zum Zitat Delgado JM, DeFeudis FV, Roth RH, et al. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 1972; 198: 9–21PubMed Delgado JM, DeFeudis FV, Roth RH, et al. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 1972; 198: 9–21PubMed
48.
Zurück zum Zitat Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228–31PubMed Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228–31PubMed
49.
Zurück zum Zitat Brunner M, Hollenstein U, Delacher S, et al. Distribution and antimicrobial activity of Ciprofloxacin in human soft tissues. Antimicrob Agents Chemother 1999; 43: 1307–9PubMed Brunner M, Hollenstein U, Delacher S, et al. Distribution and antimicrobial activity of Ciprofloxacin in human soft tissues. Antimicrob Agents Chemother 1999; 43: 1307–9PubMed
50.
Zurück zum Zitat Müller M, Mascher H, Kikuta C, et al. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62: 293–9PubMedCrossRef Müller M, Mascher H, Kikuta C, et al. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62: 293–9PubMedCrossRef
51.
Zurück zum Zitat Hollenstein U, Brunner M, Mayer BX, et al. Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers. Clin Pharmacol Ther 2000; 67: 229–36PubMedCrossRef Hollenstein U, Brunner M, Mayer BX, et al. Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers. Clin Pharmacol Ther 2000; 67: 229–36PubMedCrossRef
52.
Zurück zum Zitat Tossman U, Ungerstedt U. Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 1986; 128: 9–14PubMedCrossRef Tossman U, Ungerstedt U. Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 1986; 128: 9–14PubMedCrossRef
53.
Zurück zum Zitat Frossard M, Joukhadar C, Erovic BM, et al. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother 2000; 44: 2728–32PubMedCrossRef Frossard M, Joukhadar C, Erovic BM, et al. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother 2000; 44: 2728–32PubMedCrossRef
54.
Zurück zum Zitat Brunner M, Joukhadar C, Schmid R, et al. Validation of urea as an endogenous reference compound for the in vivo calibration of microdialysis probes. Life Sci 2000; 67: 977–84PubMedCrossRef Brunner M, Joukhadar C, Schmid R, et al. Validation of urea as an endogenous reference compound for the in vivo calibration of microdialysis probes. Life Sci 2000; 67: 977–84PubMedCrossRef
55.
Zurück zum Zitat Muller M, Rastelli C, Ferri P, et al. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998; 25: 1833–6PubMed Muller M, Rastelli C, Ferri P, et al. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998; 25: 1833–6PubMed
56.
Zurück zum Zitat Muller M, Schmid R, Georgopoulos A, et al. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57: 371–80PubMedCrossRef Muller M, Schmid R, Georgopoulos A, et al. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57: 371–80PubMedCrossRef
57.
Zurück zum Zitat Hsiao JK, Ball BA, Morrison PF, et al. Effects of different semipermeable membranes on in vitro and in vivo performance of microdialysis probes. J Neurochem 1990; 54: 1449–52PubMedCrossRef Hsiao JK, Ball BA, Morrison PF, et al. Effects of different semipermeable membranes on in vitro and in vivo performance of microdialysis probes. J Neurochem 1990; 54: 1449–52PubMedCrossRef
58.
Zurück zum Zitat Benveniste H, Hansen AJ, Ottosen NS. Determination of brain interstitial concentrations by microdialysis. J Neurochem 1989; 52: 1741–50PubMedCrossRef Benveniste H, Hansen AJ, Ottosen NS. Determination of brain interstitial concentrations by microdialysis. J Neurochem 1989; 52: 1741–50PubMedCrossRef
59.
Zurück zum Zitat Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 1994; 102: 807–11PubMedCrossRef Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 1994; 102: 807–11PubMedCrossRef
60.
Zurück zum Zitat Hickner RC, Ekelund U, Mellander S, et al. Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 1995; 79: 638–47PubMed Hickner RC, Ekelund U, Mellander S, et al. Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 1995; 79: 638–47PubMed
61.
Zurück zum Zitat Groth LJA. In vitro microdialysis of hydrophilic and lipophilic compounds. Anal Chim Acta 1997; 355: 75–83CrossRef Groth LJA. In vitro microdialysis of hydrophilic and lipophilic compounds. Anal Chim Acta 1997; 355: 75–83CrossRef
62.
Zurück zum Zitat Benfeldt E, Groth L. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 1998; 78: 274–8PubMedCrossRef Benfeldt E, Groth L. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 1998; 78: 274–8PubMedCrossRef
63.
Zurück zum Zitat Muller M, Schmid R, Wagner O, et al. In vivo characterization of transdermal drug transport by microdialysis. J Control Release 1995; 37: 49–57CrossRef Muller M, Schmid R, Wagner O, et al. In vivo characterization of transdermal drug transport by microdialysis. J Control Release 1995; 37: 49–57CrossRef
64.
Zurück zum Zitat Mayer BX, Hollenstein U, Brunner M, et al. Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteers. Electrophoresis 2000; 21: 1558–64PubMedCrossRef Mayer BX, Hollenstein U, Brunner M, et al. Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteers. Electrophoresis 2000; 21: 1558–64PubMedCrossRef
65.
Zurück zum Zitat Buerger C, Joukhadar C, Müller M, et al. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 796: 155–64PubMedCrossRef Buerger C, Joukhadar C, Müller M, et al. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 796: 155–64PubMedCrossRef
66.
Zurück zum Zitat Neckel U, Joukhadar C, Frossard M, et al. Simultaneous determination of levofloxacin and Ciprofloxacin in microdialysates and plasma by HPLC. Anal Chim Acta 2002; 463: 199–206CrossRef Neckel U, Joukhadar C, Frossard M, et al. Simultaneous determination of levofloxacin and Ciprofloxacin in microdialysates and plasma by HPLC. Anal Chim Acta 2002; 463: 199–206CrossRef
67.
Zurück zum Zitat Kurosaki Y, Nakamura S, Shiojiri Y, et al. Lipo-microdialysis: a new microdialysis method for studying the pharmacokinetics of lipophilic substances. Biol Pharm Bull 1998; 21: 194–6PubMedCrossRef Kurosaki Y, Nakamura S, Shiojiri Y, et al. Lipo-microdialysis: a new microdialysis method for studying the pharmacokinetics of lipophilic substances. Biol Pharm Bull 1998; 21: 194–6PubMedCrossRef
68.
Zurück zum Zitat Carneheim C, Stahle L. Microdialysis of lipophilic compounds: a methodological study. Pharmacol Toxicol 1991; 69: 378–80PubMedCrossRef Carneheim C, Stahle L. Microdialysis of lipophilic compounds: a methodological study. Pharmacol Toxicol 1991; 69: 378–80PubMedCrossRef
70.
71.
Zurück zum Zitat Herkner H, Klein N, Joukhadar C, et al. Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest 2003; 33: 141–6PubMedCrossRef Herkner H, Klein N, Joukhadar C, et al. Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest 2003; 33: 141–6PubMedCrossRef
72.
Zurück zum Zitat Legat FJ, Maier A, Dittrich P, et al. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother 2003; 47: 371–4PubMedCrossRef Legat FJ, Maier A, Dittrich P, et al. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother 2003; 47: 371–4PubMedCrossRef
73.
Zurück zum Zitat Lorentzen H, Kallehave F, Kolmos HJ, et al. Gentamicin concentrations in human subcutaneous tissue. Antimicrob Agents Chemother 1996; 40: 1785–9PubMed Lorentzen H, Kallehave F, Kolmos HJ, et al. Gentamicin concentrations in human subcutaneous tissue. Antimicrob Agents Chemother 1996; 40: 1785–9PubMed
74.
Zurück zum Zitat Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996; 40: 2703–9PubMed Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996; 40: 2703–9PubMed
75.
Zurück zum Zitat Muller M, Brunner M, Hollenstein U, et al. Penetration of Ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother 1999; 43: 2056–8PubMed Muller M, Brunner M, Hollenstein U, et al. Penetration of Ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother 1999; 43: 2056–8PubMed
76.
Zurück zum Zitat Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 2003; 47: 3548–53PubMedCrossRef Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 2003; 47: 3548–53PubMedCrossRef
77.
Zurück zum Zitat Joukhadar C, Stass H, Muller-Zellenberg U, et al. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother 2003; 47: 3099–103PubMedCrossRef Joukhadar C, Stass H, Muller-Zellenberg U, et al. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother 2003; 47: 3099–103PubMedCrossRef
78.
Zurück zum Zitat de PA, Brunner M, Eichler HG, et al. Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans. J Clin Pharmacol 2002; 42: 403–11CrossRef de PA, Brunner M, Eichler HG, et al. Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans. J Clin Pharmacol 2002; 42: 403–11CrossRef
79.
Zurück zum Zitat Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002; 30: 1478–82PubMedCrossRef Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002; 30: 1478–82PubMedCrossRef
80.
Zurück zum Zitat Liu P, Muller M, Grant M, et al. Interstitial tissue concentrations of cefpodoxime. J Antimicrob Chemother 2002; 50 Suppl.: 19–22PubMedCrossRef Liu P, Muller M, Grant M, et al. Interstitial tissue concentrations of cefpodoxime. J Antimicrob Chemother 2002; 50 Suppl.: 19–22PubMedCrossRef
81.
Zurück zum Zitat Gattringer R, Urbauer E, Traunmuller F, et al. Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers. Antimicrob Agents Chemother 2004 Dec; 48(12): 4650–3PubMedCrossRef Gattringer R, Urbauer E, Traunmuller F, et al. Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers. Antimicrob Agents Chemother 2004 Dec; 48(12): 4650–3PubMedCrossRef
82.
Zurück zum Zitat Dehghanyar P, Burger C, Zeitlinger M, et al. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother 2005 Jun; 49(6): 2367–71PubMedCrossRef Dehghanyar P, Burger C, Zeitlinger M, et al. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother 2005 Jun; 49(6): 2367–71PubMedCrossRef
83.
Zurück zum Zitat Plock N, Buerger C, Kloft C. Successful management of discovered pH dependence in vancomycin recovery studies: novel HPLC method for microdialysis and plasma samples. Biomed chromatogr 2005 Apr; 19(3): 237–44PubMedCrossRef Plock N, Buerger C, Kloft C. Successful management of discovered pH dependence in vancomycin recovery studies: novel HPLC method for microdialysis and plasma samples. Biomed chromatogr 2005 Apr; 19(3): 237–44PubMedCrossRef
84.
Zurück zum Zitat Hollenstein UM, Brunner M, Schmid R, et al. Soft tissue concentrations of Ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001; 25: 354–8PubMedCrossRef Hollenstein UM, Brunner M, Schmid R, et al. Soft tissue concentrations of Ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001; 25: 354–8PubMedCrossRef
85.
Zurück zum Zitat Brunner M, Reinprecht A, Illievich U, et al. Penetration of fosfomycin into the parenchyma of human brain: a case study in three patients. Br J Clin Pharmacol 2002; 54: 548–50PubMed Brunner M, Reinprecht A, Illievich U, et al. Penetration of fosfomycin into the parenchyma of human brain: a case study in three patients. Br J Clin Pharmacol 2002; 54: 548–50PubMed
86.
Zurück zum Zitat Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003; 51: 1247–52PubMedCrossRef Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003; 51: 1247–52PubMedCrossRef
87.
Zurück zum Zitat Tegeder I, Brautigam L, Podda M, et al. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen. Clin Pharmacol Ther 2002; 71: 153–61PubMedCrossRef Tegeder I, Brautigam L, Podda M, et al. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen. Clin Pharmacol Ther 2002; 71: 153–61PubMedCrossRef
88.
Zurück zum Zitat Kearney BP, Aweeka FT. The penetration of anti-infectives into the central nervous system. Neural Clin 1999; 17: 883–900CrossRef Kearney BP, Aweeka FT. The penetration of anti-infectives into the central nervous system. Neural Clin 1999; 17: 883–900CrossRef
89.
Zurück zum Zitat Barza M. Anatomical barriers for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1993; 12 Suppl. 1: S31–5PubMedCrossRef Barza M. Anatomical barriers for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1993; 12 Suppl. 1: S31–5PubMedCrossRef
90.
Zurück zum Zitat Drach GW. Prostatitis: man’s hidden infection. Ural Clin North Am 1975; 2: 499–520 Drach GW. Prostatitis: man’s hidden infection. Ural Clin North Am 1975; 2: 499–520
91.
Zurück zum Zitat Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol 1993; 111: 492–4PubMedCrossRef Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol 1993; 111: 492–4PubMedCrossRef
92.
Zurück zum Zitat Barza M, Lynch E, Baum JL. Pharmacokinetics of newer Cephalosporins after subconjunctival and intravitreal injection in rabbits. Arch Ophthalmol 1993; 111: 121–5PubMedCrossRef Barza M, Lynch E, Baum JL. Pharmacokinetics of newer Cephalosporins after subconjunctival and intravitreal injection in rabbits. Arch Ophthalmol 1993; 111: 121–5PubMedCrossRef
93.
Zurück zum Zitat Heikkinen T, Laine K, Neuvonen PJ, et al. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5PubMedCrossRef Heikkinen T, Laine K, Neuvonen PJ, et al. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5PubMedCrossRef
94.
Zurück zum Zitat Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981; 3: 67–73PubMedCrossRef Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981; 3: 67–73PubMedCrossRef
95.
96.
Zurück zum Zitat Potschka H, Fedrowitz M, Loscher W. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 2001; 12: 3557–60PubMedCrossRef Potschka H, Fedrowitz M, Loscher W. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 2001; 12: 3557–60PubMedCrossRef
97.
Zurück zum Zitat Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 2001; 1: 189–99PubMedCrossRef Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 2001; 1: 189–99PubMedCrossRef
98.
Zurück zum Zitat Sukhai M, Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci 2000; 3: 268–80PubMed Sukhai M, Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci 2000; 3: 268–80PubMed
99.
Zurück zum Zitat Huovinen P. Macrolide-resistant group A streptococcus: now in the United States. N Engl J Med 2002; 346: 1243–5PubMedCrossRef Huovinen P. Macrolide-resistant group A streptococcus: now in the United States. N Engl J Med 2002; 346: 1243–5PubMedCrossRef
100.
Zurück zum Zitat Presant CA, Wolf W, Waluch V, et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 1994; 343: 1184–7PubMedCrossRef Presant CA, Wolf W, Waluch V, et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 1994; 343: 1184–7PubMedCrossRef
101.
Zurück zum Zitat Hyatt JM, McKinnon PS, Zimmer GS, et al. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome: focus on antibacterial agents. Clin Pharmacokinet 1995; 28: 143–60PubMedCrossRef Hyatt JM, McKinnon PS, Zimmer GS, et al. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome: focus on antibacterial agents. Clin Pharmacokinet 1995; 28: 143–60PubMedCrossRef
102.
Zurück zum Zitat Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis Suppl 1978; 14: 262–6PubMed Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis Suppl 1978; 14: 262–6PubMed
103.
Zurück zum Zitat Palsmeier RK, Lunte CE. Microdialysis sampling in tumor and muscle: study of the disposition of 3-amino-1,2,4-benzotriazine-l,4-di-N-oxide (SR 4233). Life Sci 1994; 55: 815–25PubMedCrossRef Palsmeier RK, Lunte CE. Microdialysis sampling in tumor and muscle: study of the disposition of 3-amino-1,2,4-benzotriazine-l,4-di-N-oxide (SR 4233). Life Sci 1994; 55: 815–25PubMedCrossRef
104.
Zurück zum Zitat de Lange EC, de Vries JD, Zurcher C, et al. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm Res 1995; 12: 1924–31PubMedCrossRef de Lange EC, de Vries JD, Zurcher C, et al. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm Res 1995; 12: 1924–31PubMedCrossRef
105.
Zurück zum Zitat Nakashima M, Shibata S, Tokunaga Y, et al. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma. J Pharm Pharmacol 1997; 49: 777–80PubMedCrossRef Nakashima M, Shibata S, Tokunaga Y, et al. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma. J Pharm Pharmacol 1997; 49: 777–80PubMedCrossRef
106.
Zurück zum Zitat Behrens PF, Langemann H, Strohschein R, et al. Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study. J Neurooncol 2000; 47: 11–22PubMedCrossRef Behrens PF, Langemann H, Strohschein R, et al. Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study. J Neurooncol 2000; 47: 11–22PubMedCrossRef
107.
Zurück zum Zitat Darbin O, Lonjon M, Quentien MH, et al. In vivo study of tumor metabolism: an application of new multi-probe microdialysis system in the striatum of freely moving rats grafted with C6 cells. Brain Res 2000; 881: 121–7PubMedCrossRef Darbin O, Lonjon M, Quentien MH, et al. In vivo study of tumor metabolism: an application of new multi-probe microdialysis system in the striatum of freely moving rats grafted with C6 cells. Brain Res 2000; 881: 121–7PubMedCrossRef
108.
Zurück zum Zitat Wang Q, Yang H, Miller DW, et al. Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem Biophys Res Commun 1995; 211: 719–26PubMedCrossRef Wang Q, Yang H, Miller DW, et al. Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem Biophys Res Commun 1995; 211: 719–26PubMedCrossRef
109.
Zurück zum Zitat Sakata A, Tamai I, Kawazu K, et al. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994; 48: 1989–92PubMedCrossRef Sakata A, Tamai I, Kawazu K, et al. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994; 48: 1989–92PubMedCrossRef
110.
Zurück zum Zitat Tsai TH, Lee CH, Yeh PH. Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis. Br J Pharmacol 2001; 134: 1245–52PubMedCrossRef Tsai TH, Lee CH, Yeh PH. Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis. Br J Pharmacol 2001; 134: 1245–52PubMedCrossRef
111.
Zurück zum Zitat Ma J, Pulfer S, Li S, et al. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 2001; 61: 5491–8PubMed Ma J, Pulfer S, Li S, et al. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 2001; 61: 5491–8PubMed
112.
Zurück zum Zitat Teicher BA, Holden SA, Ara G, et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Cancer 1994; 57: 920–5PubMedCrossRef Teicher BA, Holden SA, Ara G, et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Cancer 1994; 57: 920–5PubMedCrossRef
113.
Zurück zum Zitat Teicher BA, Dupuis NP, Robinson MF, et al. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncol Res 1995; 7: 237–43PubMed Teicher BA, Dupuis NP, Robinson MF, et al. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncol Res 1995; 7: 237–43PubMed
114.
Zurück zum Zitat Lundstedt C, Stridbeck H, Andersson R, et al. Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 1991; 32: 518–20PubMedCrossRef Lundstedt C, Stridbeck H, Andersson R, et al. Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 1991; 32: 518–20PubMedCrossRef
115.
Zurück zum Zitat Weiss H. Metastases caused by fine needle puncture [in German]. Ultraschall Med 1989; 10: 147–51PubMedCrossRef Weiss H. Metastases caused by fine needle puncture [in German]. Ultraschall Med 1989; 10: 147–51PubMedCrossRef
116.
Zurück zum Zitat Thompson JF, Siebert GA, Anissimov YG, et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer 2001; 85: 157–65PubMedCrossRef Thompson JF, Siebert GA, Anissimov YG, et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer 2001; 85: 157–65PubMedCrossRef
117.
Zurück zum Zitat Ekstrom PO, Giercksky KE, Andersen A, et al. Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis. Life Sci 1997; 61: PL275–PL280PubMedCrossRef Ekstrom PO, Giercksky KE, Andersen A, et al. Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis. Life Sci 1997; 61: PL275–PL280PubMedCrossRef
118.
Zurück zum Zitat Ekstrom PO, Andersen A, Saeter G, et al. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report. Cancer Chemother Pharmacol 1997; 39: 267–72PubMed Ekstrom PO, Andersen A, Saeter G, et al. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report. Cancer Chemother Pharmacol 1997; 39: 267–72PubMed
119.
Zurück zum Zitat Wennberg AM, Larko O, Lonnroth P, et al. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin: a microdialysis and perfusion study. Clin Exp Dermatol 2000; 25: 317–22PubMedCrossRef Wennberg AM, Larko O, Lonnroth P, et al. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin: a microdialysis and perfusion study. Clin Exp Dermatol 2000; 25: 317–22PubMedCrossRef
120.
Zurück zum Zitat De Micheli E, Alfieri A, Pinna G, et al. Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study. Adv Exp Med Biol 2000; 483: 621–5PubMedCrossRef De Micheli E, Alfieri A, Pinna G, et al. Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study. Adv Exp Med Biol 2000; 483: 621–5PubMedCrossRef
121.
Zurück zum Zitat Hunz M, Jetter A, Wilde S, et al. Plasma and tissue pharmacokinetics of epirubicine in nine patients with primary breast cancer. Eur J Clin Pharmacol 2001; 57: A31CrossRef Hunz M, Jetter A, Wilde S, et al. Plasma and tissue pharmacokinetics of epirubicine in nine patients with primary breast cancer. Eur J Clin Pharmacol 2001; 57: A31CrossRef
122.
123.
Zurück zum Zitat Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039–51PubMed Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039–51PubMed
124.
Zurück zum Zitat Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155: 739–52PubMedCrossRef Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155: 739–52PubMedCrossRef
125.
Zurück zum Zitat Shah VP, Flynn GL, Yacobi A, et al. Bioequivalence of topical dermatological dosage forms: methods of evaluation of bioequivalence. Pharm Res 1998; 15: 167–71PubMedCrossRef Shah VP, Flynn GL, Yacobi A, et al. Bioequivalence of topical dermatological dosage forms: methods of evaluation of bioequivalence. Pharm Res 1998; 15: 167–71PubMedCrossRef
126.
Zurück zum Zitat Fang JY, Sung KC, Lin HH, et al. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm 1999; 178: 83–92PubMedCrossRef Fang JY, Sung KC, Lin HH, et al. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm 1999; 178: 83–92PubMedCrossRef
127.
Zurück zum Zitat Benfeldt E, Serup J. Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999; 291: 517–26PubMedCrossRef Benfeldt E, Serup J. Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999; 291: 517–26PubMedCrossRef
128.
Zurück zum Zitat Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm Res 2001; 18: 367–73PubMedCrossRef Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm Res 2001; 18: 367–73PubMedCrossRef
129.
Zurück zum Zitat Ding P, Xu H, Wei G, et al. Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats. Biomed Chromatogr 2000; 14: 141–3PubMedCrossRef Ding P, Xu H, Wei G, et al. Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats. Biomed Chromatogr 2000; 14: 141–3PubMedCrossRef
130.
Zurück zum Zitat Ault JM, Riley CM, Meltzer NM, et al. Dermal microdialysis sampling in vivo. Pharm Res 1994; 11: 1631–9PubMedCrossRef Ault JM, Riley CM, Meltzer NM, et al. Dermal microdialysis sampling in vivo. Pharm Res 1994; 11: 1631–9PubMedCrossRef
131.
Zurück zum Zitat Nakashima M, Zhao MF, Ohya H, et al. Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats. J Pharm Pharmacol 1996; 48: 1143–6PubMedCrossRef Nakashima M, Zhao MF, Ohya H, et al. Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats. J Pharm Pharmacol 1996; 48: 1143–6PubMedCrossRef
132.
Zurück zum Zitat Matsuyama K, Nakashima M, Nakaboh Y, et al. Application of in vivo microdialysis to transdermal absorption of methotrexate in rats. Pharm Res 1994; 11: 684–6PubMedCrossRef Matsuyama K, Nakashima M, Nakaboh Y, et al. Application of in vivo microdialysis to transdermal absorption of methotrexate in rats. Pharm Res 1994; 11: 684–6PubMedCrossRef
133.
Zurück zum Zitat Fang JY, Hsu LR, Huang YB, et al. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Int J Pharm 1999; 180: 137–49PubMedCrossRef Fang JY, Hsu LR, Huang YB, et al. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Int J Pharm 1999; 180: 137–49PubMedCrossRef
134.
Zurück zum Zitat Matsuyama K, Nakashima M, Ichikawa M, et al. In vivo microdialysis for the transdermal absorption of Valproate in rats. Biol Pharm Bull 1994; 17: 1395–8PubMedCrossRef Matsuyama K, Nakashima M, Ichikawa M, et al. In vivo microdialysis for the transdermal absorption of Valproate in rats. Biol Pharm Bull 1994; 17: 1395–8PubMedCrossRef
135.
Zurück zum Zitat Murakami T, Yoshioka M, Yumoto R, et al. Topical delivery of keloid therapeutic drug, tranilast, by combined use of oleic acid and propylene glycol as a penetration enhancer: evaluation by skin microdialysis in rats. J Pharm Pharmacol 1998; 50: 49–54PubMedCrossRef Murakami T, Yoshioka M, Yumoto R, et al. Topical delivery of keloid therapeutic drug, tranilast, by combined use of oleic acid and propylene glycol as a penetration enhancer: evaluation by skin microdialysis in rats. J Pharm Pharmacol 1998; 50: 49–54PubMedCrossRef
136.
Zurück zum Zitat Stagni G, O’Donnell D, Liu YJ, et al. Intradermal microdialysis: kinetics of iontophoretically delivered Propranolol in forearm dermis. J Control Release 2000; 63: 331–9PubMedCrossRef Stagni G, O’Donnell D, Liu YJ, et al. Intradermal microdialysis: kinetics of iontophoretically delivered Propranolol in forearm dermis. J Control Release 2000; 63: 331–9PubMedCrossRef
137.
Zurück zum Zitat Anderson C, Andersson T, Boman A, et al. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Probl Dermatol 1996; 25: 37–46PubMed Anderson C, Andersson T, Boman A, et al. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Probl Dermatol 1996; 25: 37–46PubMed
138.
Zurück zum Zitat Boelsma E, Anderson C, Karlsson AM, et al. Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo. Pharm Res 2000; 17: 141–7PubMedCrossRef Boelsma E, Anderson C, Karlsson AM, et al. Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo. Pharm Res 2000; 17: 141–7PubMedCrossRef
139.
Zurück zum Zitat Benfeldt E, Serup J, Menne T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999; 140: 739–48PubMedCrossRef Benfeldt E, Serup J, Menne T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999; 140: 739–48PubMedCrossRef
140.
Zurück zum Zitat Hegemann L, Forstinger C, Partsch B, et al. Microdialysis in cutaneous pharmacology: kinetic analysis of transdermally delivered nicotine. J Invest Dermatol 1995; 104: 839–43PubMedCrossRef Hegemann L, Forstinger C, Partsch B, et al. Microdialysis in cutaneous pharmacology: kinetic analysis of transdermally delivered nicotine. J Invest Dermatol 1995; 104: 839–43PubMedCrossRef
141.
Zurück zum Zitat Schrolnberger C, Brunner M, Mayer BX, et al. Application of the minimal trauma biopsy to transdermal clinical pharmacokinetic studies. J Control Release 2001; 75: 297–306PubMedCrossRef Schrolnberger C, Brunner M, Mayer BX, et al. Application of the minimal trauma biopsy to transdermal clinical pharmacokinetic studies. J Control Release 2001; 75: 297–306PubMedCrossRef
142.
Zurück zum Zitat Tegeder I, Muth-Selbach U, Lotsch J, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther 1999; 65: 357–68PubMedCrossRef Tegeder I, Muth-Selbach U, Lotsch J, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther 1999; 65: 357–68PubMedCrossRef
143.
Zurück zum Zitat Anderson C, Andersson T, Molander M. Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol 1991; 71: 389–93PubMed Anderson C, Andersson T, Molander M. Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol 1991; 71: 389–93PubMed
144.
Zurück zum Zitat Stagni G, O’Donnell D, Liu YJ, et al. Iontophoretic current and intradermal microdialysis recovery in humans. J Pharmacol Toxicol Methods 1999; 41: 49–54PubMedCrossRef Stagni G, O’Donnell D, Liu YJ, et al. Iontophoretic current and intradermal microdialysis recovery in humans. J Pharmacol Toxicol Methods 1999; 41: 49–54PubMedCrossRef
145.
Zurück zum Zitat Benfeldt E. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration: studies in hairless rats and human subjects. Acta Derm Venereol Suppl (Stockh) 1999; 206: 1–59 Benfeldt E. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration: studies in hairless rats and human subjects. Acta Derm Venereol Suppl (Stockh) 1999; 206: 1–59
146.
Zurück zum Zitat Cormier M, Chao ST, Gupta SK, et al. Effect of transdermal iontophoresis codelivery of hydrocortisone on metoclopramide pharmacokinetics and skin-induced reactions in human subjects. J Pharm Sci 1999; 88: 1030–5PubMedCrossRef Cormier M, Chao ST, Gupta SK, et al. Effect of transdermal iontophoresis codelivery of hydrocortisone on metoclopramide pharmacokinetics and skin-induced reactions in human subjects. J Pharm Sci 1999; 88: 1030–5PubMedCrossRef
147.
Zurück zum Zitat Boutsiouki P, Thompson JP, Clough GF. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch Toxicol 2001; 75: 321–8PubMedCrossRef Boutsiouki P, Thompson JP, Clough GF. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch Toxicol 2001; 75: 321–8PubMedCrossRef
148.
Zurück zum Zitat Liu P, Muller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002; 19: 285–90PubMedCrossRef Liu P, Muller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002; 19: 285–90PubMedCrossRef
149.
Zurück zum Zitat Meibohm B, Derendorf H. Pharmacokinetic/pharmacodynamic studies in drug product development. J Pharm Sci 2002; 91: 18–31PubMedCrossRef Meibohm B, Derendorf H. Pharmacokinetic/pharmacodynamic studies in drug product development. J Pharm Sci 2002; 91: 18–31PubMedCrossRef
150.
Zurück zum Zitat Delacher S, Derendorf H, Hollenstein U, et al. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother 2000; 46: 733–9PubMedCrossRef Delacher S, Derendorf H, Hollenstein U, et al. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother 2000; 46: 733–9PubMedCrossRef
151.
Zurück zum Zitat Sauermann R, Zeitlinger M, Erovic BM, et al. Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int J Antimicrob Agents 2003; 22: 574–8PubMedCrossRef Sauermann R, Zeitlinger M, Erovic BM, et al. Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int J Antimicrob Agents 2003; 22: 574–8PubMedCrossRef
152.
Zurück zum Zitat Zeitlinger MA, Marsik C, Georgopoulos A, et al. Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. Int J Antimicrob Agents 2003; 21: 562–7PubMedCrossRef Zeitlinger MA, Marsik C, Georgopoulos A, et al. Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. Int J Antimicrob Agents 2003; 21: 562–7PubMedCrossRef
153.
Zurück zum Zitat Muller M, Bockenheimer J, Zellenberg U, et al. Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients. Breast Cancer Res Treat 2000; 60: 211–7PubMedCrossRef Muller M, Bockenheimer J, Zellenberg U, et al. Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients. Breast Cancer Res Treat 2000; 60: 211–7PubMedCrossRef
154.
Zurück zum Zitat Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000; 41: 661–81PubMed Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000; 41: 661–81PubMed
155.
Zurück zum Zitat Front D, Israel O, Iosilevsky G, et al. Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake. Radiology 1987; 165: 129–33PubMed Front D, Israel O, Iosilevsky G, et al. Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake. Radiology 1987; 165: 129–33PubMed
156.
Zurück zum Zitat Sundram FX, Wong WY, Ang ES, et al. Evaluation of technetium-99m Ciprofloxacin (Infecton) in the imaging of infection. Ann Acad Med Singapore 2000; 29: 699–703PubMed Sundram FX, Wong WY, Ang ES, et al. Evaluation of technetium-99m Ciprofloxacin (Infecton) in the imaging of infection. Ann Acad Med Singapore 2000; 29: 699–703PubMed
157.
Zurück zum Zitat Fischman AJ, Livni E, Babich J, et al. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother 1993; 37: 2144–52PubMedCrossRef Fischman AJ, Livni E, Babich J, et al. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother 1993; 37: 2144–52PubMedCrossRef
158.
Zurück zum Zitat Wollmer P, Pride NB, Rhodes CG, et al. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet 1982; II: 1361–4CrossRef Wollmer P, Pride NB, Rhodes CG, et al. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet 1982; II: 1361–4CrossRef
159.
Zurück zum Zitat Tewson TJ, Yang D, Wong G, et al. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies. Nucl Med Biol 1996; 23: 767–72PubMedCrossRef Tewson TJ, Yang D, Wong G, et al. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies. Nucl Med Biol 1996; 23: 767–72PubMedCrossRef
160.
Zurück zum Zitat Jynge P, Skjetne T, Gribbestad I, et al. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther 1990; 48: 481–9PubMedCrossRef Jynge P, Skjetne T, Gribbestad I, et al. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther 1990; 48: 481–9PubMedCrossRef
161.
Zurück zum Zitat Fischman AJ, Alpert NM, Livni E, et al. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother 1993; 37: 1270–7PubMedCrossRef Fischman AJ, Alpert NM, Livni E, et al. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother 1993; 37: 1270–7PubMedCrossRef
162.
Zurück zum Zitat Fischman AJ, Alpert NM, Babich JW, et al. The role of positron emission tomography in pharmacokinetic analysis. Drug Metab Rev 1997; 29: 923–56PubMedCrossRef Fischman AJ, Alpert NM, Babich JW, et al. The role of positron emission tomography in pharmacokinetic analysis. Drug Metab Rev 1997; 29: 923–56PubMedCrossRef
Metadaten
Titel
Microdialysis
Current Applications in Clinical Pharmacokinetic Studies and its Potential Role in the Future
verfasst von
Dr Christian Joukhadar
Markus Müller
Publikationsdatum
01.09.2005
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 9/2005
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/00003088-200544090-00002

Weitere Artikel der Ausgabe 9/2005

Clinical Pharmacokinetics 9/2005 Zur Ausgabe